Anti-EGFR (epidermal growth factor receptor) Skin Toxicity App app for iPhone and iPad

The Anti-EGFR skin toxicity app is designed as an aid for healthcare professionals and contains educational materials and treatment recommendations based on consensus from an Irish Advisory Panel (Oncology, Dermatology and Specialist Nurses) relating to the management of dermatologic toxicities in patients treated using monoclonal antibodies and small-molecule inhibitors directed towards the (epidermal growth factor receptor) EGFR.

The Anti-EGFR skin toxicity app provides information regarding grading of these side effects and treatment recommendations in an easy to navigate format. It assists healthcare professionals in making appropriate decisions and allows them to access key information via their smartphone and offer advice to patients at point of care.

Please note: This application is intended for use by healthcare professionals only. It is not designed for patient use and does not replace the advice of a doctor.